WHO ICTRP trial

A randomised feasibility study to assess the use of serial magnetic resonance…

ISRCTN74101606 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting

Key facts

Trial ID ISRCTN74101606
Public title A randomised feasibility study to assess the use of serial magnetic resonance imaging to reduce treatment times in Charcot neuroarthropathy in people with diabetes
Scientific title A randomised feasibility trial to define outcome measures for acute Charcot neuroarthropathy in Diabetes and their use in assessing clinical management
Primary sponsor Norfolk and Norwich University Hospitals NHS Foundation Trust
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries United Kingdom;England
Conditions Diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus
Interventions This study is a 2-arm open labelled randomised controlled study. It investigates the feasibility of using serial MRI to monitor CN. The study lasts for 3 years. There is an 18-month recruitment period with a further 18 month follow-up…
Registration date Oct 11, 2017
Target size 60
Secondary IDs 35344
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations